NCT07714512: Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 32 planned
- Started
- 30 Jun 2026
- Primary completion
- 30 Jun 2028
- Arms
- Isatuximab
- Results
- None posted
- 30 Jun 2026: Trial started
- 20 Jul 2026: Trial registered